{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17900043", "DateCompleted": {"Year": "2007", "Month": "11", "Day": "26"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1078-6791", "JournalIssue": {"Volume": "13", "Issue": "5", "PubDate": {"Year": "2007", "Season": "Sep-Oct"}}, "Title": "Alternative therapies in health and medicine", "ISOAbbreviation": "Altern Ther Health Med"}, "ArticleTitle": "Potential of rosemary oil to be used in drug-resistant infections.", "Pagination": {"StartPage": "54", "EndPage": "59", "MedlinePgn": "54-9"}, "Abstract": {"AbstractText": ["To evaluate the antimicrobial activity potential of the essential oil of rosemary specifically for its efficacy against the drug-resistant mutants of Mycobacterium smegmatis, Escherichia coli, and Candida albicans.", "Antibacterial, antifungal, and drug resistance-modifying activity was evaluated both qualitatively and quantitatively following disc diffusion and broth dilution assay procedures.", "The rosemary essential oil was found to be more active against the gram-positive pathogenic bacteria except E. faecalis and drug-resistant mutants of E. coli, compared to gram-negative bacteria. Similarly, it was found to be more active toward nonfilamentous, filamentous, dermatophytic pathogenic fungi and drug-resistant mutants of Candida albicans.", "Our findings suggest that characterization and isolation of the active compound(s) from the rosemary oil may be useful in counteracting gram-positive bacterial, fungal, and drug-resistant infections."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Genetic Resources and Biotechnology Division, Central Institute of Medicinal and Aromatic Plants (Council of Scientific and Industrial Research), Lucknow, India."}], "Identifier": [], "LastName": "Luqman", "ForeName": "Suaib", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Dwivedi", "ForeName": "Gaurav R", "Initials": "GR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Darokar", "ForeName": "Mahendra P", "Initials": "MP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kalra", "ForeName": "Alok", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Khanuja", "ForeName": "Suman P S", "Initials": "SP"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Altern Ther Health Med", "NlmUniqueID": "9502013", "ISSNLinking": "1078-6791"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils, Volatile"}, {"RegistryNumber": "8LGU7VM393", "NameOfSubstance": "rosemary oil"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Bacterial Infections"}, {"QualifierName": ["drug effects"], "DescriptorName": "Candida albicans"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Microbial"}, {"QualifierName": ["drug effects"], "DescriptorName": "Escherichia coli"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Mycobacterium smegmatis"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Oils, Volatile"}, {"QualifierName": [], "DescriptorName": "Rosmarinus"}], "NumberOfReferences": "73"}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2007", "Month": "9", "Day": "29", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "12", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "9", "Day": "29", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17900043"]}}], "PubmedBookArticle": []}